Science Explorer Interactive view Map
Company · Parsippany · United States

Daiichi Sankyo (United States)

In research, Daiichi Sankyo (United States) stands highest in Medicine (#4,256 of 10,443 worldwide) and Health Sciences (#5,345 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 14.5× its share of world research.

dsi.com/homeROR OpenAlex
World rank, 2022–2025
#13,138
of 28,054 · #9,545 all time
Rank in United States
#1,820
of 4,192
Research works
584
▲ 21% vs 2013–17
Citations
15k
26.3 per fractional work
Top-10% rate
17.4%
record average 16.5%
Open access
41%
world 28%

What is Daiichi Sankyo (United States) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #4,256 of 10,443 19.5%98 #1805
Health SciencesDomain #5,345 of 11,982 18.5%104 #2366

Each strip is that field’s whole ranked pool, with the notch where Daiichi Sankyo (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Daiichi Sankyo (United States) specialise in?

Where its research is concentrated relative to its size: Oncology takes 14.5× the share of its output that it takes of world research.

  1. OncologySubfield · 25.5 works14×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.94× its world share, 16 worksBiochemistry, Geneti…Immunology and Microbiology: 2.48× its world share, 4 worksImmunology and Micro…Neuroscience: 0.35× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.66× its world share, 2 worksPharmacology, Toxico…Chemical Engineering: 1.22× its world share, 1 worksChemical EngineeringChemistry: 0.51× its world share, 1 worksChemistryComputer Science: 0.12× its world share, 1 worksComputer ScienceEngineering: 0.05× its world share, 1 worksEngineeringEnvironmental Science: 0.15× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.08× its world share, 0 worksMaterials ScienceMathematics: 2.42× its world share, 4 worksMathematicsPhysics and Astronomy: 0.30× its world share, 1 worksPhysics and AstronomyDentistry: 0.06× its world share, 0 worksDentistryHealth Professions: 1.18× its world share, 5 worksHealth ProfessionsMedicine: 3.27× its world share, 98 worksMedicineNursing: 1.38× its world share, 1 worksNursingArts and Humanities: 0.17× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.08× its world share, 0 worksBusiness, Management…Decision Sciences: 1.04× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 2.18× its world share, 7 worksEconomics, Econometr…Psychology: 0.74× its world share, 4 worksPsychologySocial Sciences: 0.17× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 3.7×. Every wedge is a field page.

Who are the top researchers at Daiichi Sankyo (United States)?

Ranked on the composite score, Maribel Salas, Martin Unverdorben and Ophelia Yin lead among researchers whose main affiliation is Daiichi Sankyo (United States).

  1. 1 Maribel Salas United States · #209,036 worldwide 142 citations · 24 works
  2. 2 Martin Unverdorben United States · #764,645 worldwide 29 citations · 28 works
  3. 3 Ophelia Yin United States · #877,690 worldwide 42 citations · 17 works
  4. 4 Madan G. Kundu United States · #929,062 worldwide 35 citations · 22 works
  5. 5 Abderrahmane Laadem United States · #1,515,940 worldwide 8 citations · 18 works
  6. 6 Rajiv Mallick United States · #1,612,528 worldwide 4 citations · 16 works
All ranked researchers at Daiichi Sankyo (United States)

Which keywords describe research at Daiichi Sankyo (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Targeted Therapy, Clinical Trials, Breast Cancer, Prognostic Factors, Monoclonal Antibody, Biomarkers and Trastuzumab.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy23▲ 21×17 topics
  2. Targeted Therapy15▲ 43×4 topics
  3. Clinical Trials15▲ 14×11 topics
  4. Breast Cancer13▲ 35×5 topics
  5. Prognostic Factors11▲ 16×9 topics
  6. Monoclonal Antibody9▲ 111×2 topics
  7. Biomarkers9▲ 8.3×9 topics
  8. Trastuzumab9▲ 123×2 topics
  9. Metastatic9▲ 88×2 topics
  10. Receptor tyrosine kinases9▲ 157×2 topics
  11. EGFR8▲ 192×1 topic
  12. HER28▲ 192×1 topic
  13. Immunotherapy8▲ 7.5×13 topics
  14. Genomic Profiling8▲ 50×2 topics
  15. ALK Inhibitors8▲ 81×1 topic
  16. EGFR Mutations8▲ 81×1 topic
  17. Clinical Practice Guidelines8▲ 8.9×9 topics
  18. Metastatic Breast Cancer7▲ 77×2 topics
  19. Quality of Life7▲ 3.0×11 topics
  20. Radiotherapy6▲ 11×9 topics
  21. Metastasis6▲ 12×8 topics
  22. Survival Analysis6▲ 14×7 topics
  23. Monoclonal Antibodies6▲ 40×3 topics
  24. Catheter Ablation6▲ 29×2 topics
  25. Guidelines6▲ 7.5×7 topics
  26. Anticoagulant Therapy5▲ 27×2 topics
  27. Atrial Fibrillation5▲ 32×1 topic
  28. Risk Stratification5▲ 44×1 topic
  29. Stroke Prevention5▲ 26×2 topics
  30. Glycosylation5▲ 27×3 topics
  31. Genomic Profiles5▲ 71×1 topic
  32. Small-Cell Lung Cancer5▲ 71×1 topic
  33. Therapeutic Antibodies5▲ 43×2 topics
  34. Tumor Markers5▲ 37×2 topics
  35. Molecular Subtypes5▲ 35×2 topics
  36. Adjuvant Therapy4▲ 21×2 topics
  37. CDK4/6 Inhibitors4▲ 102×1 topic
  38. Palbociclib4▲ 102×1 topic
  39. Antibody Engineering4▲ 46×1 topic
  40. Fc Receptors4▲ 46×1 topic

Which research topics does Daiichi Sankyo (United States) publish most on?

By volume in 2022–2025: HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations, Atrial Fibrillation Management and Outcomes and Lung Cancer Research Studies.

HER2/EGFR in Cancer Research: 8 fractional worksLung Cancer Treatments and Mutations: 8 fractional worksAtrial Fibrillation Mana…5Atrial Fibrillation Management and Outcomes: 5 fractional worksLung Cancer Research Stu…5Lung Cancer Research Studies: 5 fractional worksAdvanced Breast Cancer Therapies: 4 fractional worksMonoclonal and Polyclonal Antibodies Research: 4 fractional worksStatistical Methods in C…3Statistical Methods in Clinical Trials: 3 fractional worksAcute Myeloid Leukemia Research: 3 fractional worksCancer Treatment and Pharmacology: 3 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 3 fractional works
OncologyPulmonary and Respiratory MedicineCardiology and Cardiovascular MedicineRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 HER2/EGFR in Cancer Research Oncology 8 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 8 works
  3. 3 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 5 works
  4. 4 Lung Cancer Research Studies Oncology 5 works
  5. 5 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 4 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 4 works
  7. 7 Statistical Methods in Clinical Trials Statistics and Probability 3 works
  8. 8 Acute Myeloid Leukemia Research Hematology 3 works
  9. 9 Cancer Treatment and Pharmacology Oncology 3 works
  10. 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 3 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.4%not open58.6%

World: 28% of research is openly available.

with international co-authors48.3%domestic only51.7%

World: 19% is written across borders.

How has Daiichi Sankyo (United States)'s research output changed?

Output in 2018–2022 was 21% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Parsippany

All research institutions in Parsippany

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.